MedPath

Comparison of latanoprost and timolol in the treatment for exfoliation glaucoma: A randomized controlled trial.

Not Applicable
Conditions
Exfoliation glaucoma
Registration Number
JPRN-C000000425
Lead Sponsor
Department of Ophthalmology and Visual Science, Kumamoto University Graduate School of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1. Severe visual field defect. 2. The treatment with latanoprost or timolol within the last 28 days. 3. Allergy to latanoprost or timolol. 4. The past histories of intraocular surgery within the last 3 months or glaucoma surgery. 5. The patients with asthma, heart failure, severe diabetes mellitus or pregnancy. 6. The patients who participated in another drug study within 30 days. 7. Judged inappropriate for this study by the physicians.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath